ASTRAZENECA PLC (AZN)
Clinical trial NCT07534592 updates: 1. completion date: 2026-08-28 → 2026-10-01 2. primary completion date: 2026-08-28 → 2026-10-01
Clinical trial NCT07534592 updates: 1. completion date: 2026-08-28 → 2026-10-01 2. primary completion date: 2026-08-28 → 2026-10-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical